Meeting
2023 ASCO Annual Meeting
Spatial relationships and immune subsets in the tumor immune microenvironment of head and neck cancers.
Authors
Leanne E. Henry
University of Michigan, Ann Arbor, MI
Leanne E. Henry , Santhoshi Krishnan , Siddhi Patil , Emily Bellile , Chamila D. Perera , Shiting Li , Tingting Qin , Jeremy M.G. Taylor , Arvind Rao , Steven B. Chinn , Laura S. Rozek , Maureen A. Sartor
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 6061)
DOI
10.1200/JCO.2023.41.16_suppl.6061
Abstract #
6061
Poster Bd #
53
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Afatinib and pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma (ALPHA Study): A phase II study with biomarker analysis.
First Author: Hsiang-fong Kao
Poster
2020 ASCO Virtual Scientific Program
INDUCE-3: A randomized, double-blind study of GSK3359609 (GSK609), an inducible T-cell co-stimulatory (ICOS) agonist antibody, plus pembrolizumab (PE) versus placebo (PL) plus PE for first-line treatment of PD-L1-positive recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC).
First Author: Aaron Richard Hansen
Poster
2020 ASCO Virtual Scientific Program
HANNA: Real-world outcomes from an observational study with nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck in Germany.
First Author: Andreas Dietz
Poster
2018 Genitourinary Cancers Symposium
Effect of detecting asymptomatic recurrence after radical cystectomy on prognosis in patients with muscle invasive bladder cancer.
First Author: Shingo Hatakeyama